Supira Medical, Inc.: Supira Medical's Percutaneous Ventricular Assist Device (pVAD) to be Highlighted During PCR Innovator's Day and SCAI 2023

Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic

Related Keywords

Palais ,Rhôalpes ,France ,Phoenix ,Arizona ,United States ,California ,Paris ,France General ,Nitin Salunke ,Katie Arnold ,Gagan Singh ,Amr Salahieh ,First Floor Of The Phoenix Convention Center ,Clinical Research ,Clinical Cardiovascular Research At University Of California ,Prnewswire Supira Medical Inc ,Clinical Research Session ,European Association Of Percutaneous Cardiovascular Interventions ,Society For Cardiovascular Angiography ,Supira Medical Inc ,Late Breaking Clinical Research Session ,European Association ,Percutaneous Cardiovascular Interventions ,Clinical Cardiovascular Research ,Heart Failure ,Theatre Havane ,Palais De Congr ,Supira Medical ,Late Breaking Clinical Research ,Cardiovascular Angiography ,First Floor ,Phoenix Convention ,Gefallene Big Techs ,Supira ,Medical ,Percutaneous ,Ventricular ,Bassist ,Device ,Lvad ,Ighlighted ,During ,Innovator ,Cai ,023 ,